Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Resource Type
Article
Authors
Rittmeyer, Achim ; Barlesi, Fabrice ; Waterkamp, Daniel ; Park, Keunchil ; Ciardiello, Fortunato ; von Pawel, Joachim ; Gadgeel, Shirish M ; Hida, Toyoaki ; Kowalski, Dariusz M ; Dols, Manuel Cobo ; Cortinovis, Diego L ; Leach, Joseph ; Polikoff, Jonathan ; Barrios, Carlos ; Kabbinavar, Fairooz ; Frontera, Osvaldo Arén ; De Marinis, Filippo ; Turna, Hande ; Lee, Jong-Seok ; Ballinger, Marcus ; Kowanetz, Marcin ; He, Pei ; Chen, Daniel S ; Sandler, Alan ; Gandara, David R
Source
In The Lancet 21-27 January 2017 389(10066):255-265
Subject
Primary Research Articles
Language
ISSN
0140-6736